| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $39.9M | +92.6% | +221.5% |
| R&D Expense | $66.3M | -35.9% | +99.8% |
| SG&A Expense | $82.5M | +71.5% | +476.1% |
| Operating Income | -$168.8M | -5.1% | -217.7% |
| Pre-tax Income | -$1.06B | -449.8% | -1919.9% |
| Income Tax | -$4.4M | +70.9% | — |
| Net Income | -$1.05B |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $346.0M | +147.0% | +1046.9% |
| Short-term Investments | $736.3M | +81.0% | +119.4% |
| Accounts Receivable | $36.9M | +93.1% | +792.2% |
| Inventory | $8.7M | -0.6% | — |
| Current Assets | $1.22B | +94.2% | +207.4% |
| Total Assets |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$208.7M | — | — |
| Capital Expenditures | $7.6M | — | — |
| Investing Cash Flow | -$873.6M | — | — |
| Financing Cash Flow | $1.38B | — | — |
| Free Cash Flow | -$216.3M | — | — |
| -496.6% |
| -1909.6% |
| EPS (Basic) | -$3.58 | -411.4% | -1391.7% |
| EPS (Diluted) | -$3.58 | -411.4% | -1391.7% |
| $4.32B |
| +220.8% |
| +767.5% |
| Current Liabilities | $139.3M | +72.7% | +330.9% |
| Total Liabilities | $2.03B | +1108.1% | +3164.7% |
| Stockholders' Equity | $2.27B | +95.7% | +421.8% |